Novartis–LEE011
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Novartis–LEE011

› Forums › General Melanoma Community › Novartis–LEE011

  • Post
    • December 6, 2013 at 8:44 pm
    Scuba Doc
    Participant

    Anyone have any experience with the Novartis drug –LEE011 for CDK4/6 and any severe side effects.I am possibly starting a clinical trial next week—-thanks in advance —-LindaG

Viewing 2 reply threads
  • Replies
      • December 6, 2013 at 11:36 pm
      POW
      Participant

      The LEE011 Phase 1 clinical trials are brand new– just announced within the last month or so– so not very many of the folks here have experience with it yet.

      Apparently, LEE011 is a small molecule similar to MEK in some respects. Although researchers  hope that it will kill breast cancer, melanoma, and some other cancers, what they really expect is that it will perform especially well in combination  with other small molecule targeted treatments like the BRAF inhibitors by preventing the cancer cells from becoming resistant to the targeted therapies. 

      This is all pie-in-the-sky right now, but a series of Phase 1 trials of LEE011 alone and in combination have begun. Let's keep our fingers crossed! Please keep us posted about how things go for you.

      • December 6, 2013 at 11:36 pm
      POW
      Participant

      The LEE011 Phase 1 clinical trials are brand new– just announced within the last month or so– so not very many of the folks here have experience with it yet.

      Apparently, LEE011 is a small molecule similar to MEK in some respects. Although researchers  hope that it will kill breast cancer, melanoma, and some other cancers, what they really expect is that it will perform especially well in combination  with other small molecule targeted treatments like the BRAF inhibitors by preventing the cancer cells from becoming resistant to the targeted therapies. 

      This is all pie-in-the-sky right now, but a series of Phase 1 trials of LEE011 alone and in combination have begun. Let's keep our fingers crossed! Please keep us posted about how things go for you.

      • December 6, 2013 at 11:36 pm
      POW
      Participant

      The LEE011 Phase 1 clinical trials are brand new– just announced within the last month or so– so not very many of the folks here have experience with it yet.

      Apparently, LEE011 is a small molecule similar to MEK in some respects. Although researchers  hope that it will kill breast cancer, melanoma, and some other cancers, what they really expect is that it will perform especially well in combination  with other small molecule targeted treatments like the BRAF inhibitors by preventing the cancer cells from becoming resistant to the targeted therapies. 

      This is all pie-in-the-sky right now, but a series of Phase 1 trials of LEE011 alone and in combination have begun. Let's keep our fingers crossed! Please keep us posted about how things go for you.

        • December 7, 2013 at 1:21 pm
        Scuba Doc
        Participant

        Thank You for the reply —looks like I will be starting the trial soon—-I will keep you posted–  LindaG

        • December 7, 2013 at 1:21 pm
        Scuba Doc
        Participant

        Thank You for the reply —looks like I will be starting the trial soon—-I will keep you posted–  LindaG

        • December 7, 2013 at 1:21 pm
        Scuba Doc
        Participant

        Thank You for the reply —looks like I will be starting the trial soon—-I will keep you posted–  LindaG

        • December 8, 2013 at 1:34 am
        BrianP
        Participant

        Best of luck to you Linda.  My hat goes off to you brave phase I'ners who are willing to take a chance so that others may benefit.  Look forward to your future post and pray for great results.  Where will you be enrolling in the trial?

        Brian

        • December 8, 2013 at 1:43 pm
        Scuba Doc
        Participant

        Starting the trial at Dana-Farber Cancer Institute in Boston, MA.in the next couple of weeks —-thanks

        • January 11, 2014 at 3:51 pm
        Scuba Doc
        Participant

        We are also wondering if anyone knows if Merck has approved of a 'Compassionate Exemption' for the drug Lambrolizumab to any melanoma patient so far? 

        • January 11, 2014 at 3:51 pm
        Scuba Doc
        Participant

        We are also wondering if anyone knows if Merck has approved of a 'Compassionate Exemption' for the drug Lambrolizumab to any melanoma patient so far? 

        • January 11, 2014 at 3:51 pm
        Scuba Doc
        Participant

        We are also wondering if anyone knows if Merck has approved of a 'Compassionate Exemption' for the drug Lambrolizumab to any melanoma patient so far? 

        • January 30, 2014 at 9:27 pm
        Scuba Doc
        Participant

        We are now in the 2nd cycle —-3 weeks on 1 week off. Won't know of any changes after cts and mri for another 3 weeks. Very tired about 1 hour after taking the drug but no other side effects to speak of—-

        • January 30, 2014 at 9:27 pm
        Scuba Doc
        Participant

        We are now in the 2nd cycle —-3 weeks on 1 week off. Won't know of any changes after cts and mri for another 3 weeks. Very tired about 1 hour after taking the drug but no other side effects to speak of—-

        • January 30, 2014 at 9:27 pm
        Scuba Doc
        Participant

        We are now in the 2nd cycle —-3 weeks on 1 week off. Won't know of any changes after cts and mri for another 3 weeks. Very tired about 1 hour after taking the drug but no other side effects to speak of—-

        • March 24, 2014 at 2:08 pm
        Scuba Doc
        Participant

        CTs and MRIs show additional growth —- off of the trial and looking into another clinical trial in NYC —thanks to all of the contributors—– Linda G

        • March 24, 2014 at 2:08 pm
        Scuba Doc
        Participant

        CTs and MRIs show additional growth —- off of the trial and looking into another clinical trial in NYC —thanks to all of the contributors—– Linda G

        • March 24, 2014 at 2:08 pm
        Scuba Doc
        Participant

        CTs and MRIs show additional growth —- off of the trial and looking into another clinical trial in NYC —thanks to all of the contributors—– Linda G

        • March 24, 2014 at 8:20 pm
        POW
        Participant

        Oh, shoot! I'm sorry for your disappointment. But thank you so much for volunteering to help test out this new drug. Without people like you, melanoma research would be dead in the water. 

        I assume that you know that Merck's anti-PD1 (MK-3475) is just becoming available for expanded access? Could that be an option for you? Or perhaps an antibody-drug conjugate (ADC) trial?

        • March 24, 2014 at 8:20 pm
        POW
        Participant

        Oh, shoot! I'm sorry for your disappointment. But thank you so much for volunteering to help test out this new drug. Without people like you, melanoma research would be dead in the water. 

        I assume that you know that Merck's anti-PD1 (MK-3475) is just becoming available for expanded access? Could that be an option for you? Or perhaps an antibody-drug conjugate (ADC) trial?

        • March 24, 2014 at 8:20 pm
        POW
        Participant

        Oh, shoot! I'm sorry for your disappointment. But thank you so much for volunteering to help test out this new drug. Without people like you, melanoma research would be dead in the water. 

        I assume that you know that Merck's anti-PD1 (MK-3475) is just becoming available for expanded access? Could that be an option for you? Or perhaps an antibody-drug conjugate (ADC) trial?

        • December 8, 2013 at 1:43 pm
        Scuba Doc
        Participant

        Starting the trial at Dana-Farber Cancer Institute in Boston, MA.in the next couple of weeks —-thanks

        • December 8, 2013 at 1:43 pm
        Scuba Doc
        Participant

        Starting the trial at Dana-Farber Cancer Institute in Boston, MA.in the next couple of weeks —-thanks

        • December 8, 2013 at 1:34 am
        BrianP
        Participant

        Best of luck to you Linda.  My hat goes off to you brave phase I'ners who are willing to take a chance so that others may benefit.  Look forward to your future post and pray for great results.  Where will you be enrolling in the trial?

        Brian

        • December 8, 2013 at 1:34 am
        BrianP
        Participant

        Best of luck to you Linda.  My hat goes off to you brave phase I'ners who are willing to take a chance so that others may benefit.  Look forward to your future post and pray for great results.  Where will you be enrolling in the trial?

        Brian

Viewing 2 reply threads
  • You must be logged in to reply to this topic.
About the MRF Patient Forum

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.